MX2017007852A - Formulaciones de acido hipocloroso y metodos para tratar afecciones de la piel. - Google Patents
Formulaciones de acido hipocloroso y metodos para tratar afecciones de la piel.Info
- Publication number
- MX2017007852A MX2017007852A MX2017007852A MX2017007852A MX2017007852A MX 2017007852 A MX2017007852 A MX 2017007852A MX 2017007852 A MX2017007852 A MX 2017007852A MX 2017007852 A MX2017007852 A MX 2017007852A MX 2017007852 A MX2017007852 A MX 2017007852A
- Authority
- MX
- Mexico
- Prior art keywords
- skin
- methods
- hypochlorous acid
- skin conditions
- treating skin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención en varios aspectos y modalidades proporciona métodos y formulaciones para tratar afecciones inflamatorias de la piel y/o afecciones que implican función de barrera cutánea comprometida. Tales enfermedades implican enfermedades ampollosas de la piel, defectos hereditarios en la función de barrera cutánea, afecciones hiperproliferativas que involucran la piel, afecciones asociadas con el envejecimiento o piel dañada, trastornos inmunológicos que involucran la piel, entre otros.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/572,378 US9381214B2 (en) | 2011-03-18 | 2014-12-16 | Methods for treating skin irritation |
US14/670,641 US9999635B2 (en) | 2007-01-16 | 2015-03-27 | Methods and compositions for treating inflammatory disorders |
PCT/US2015/066147 WO2016100543A2 (en) | 2014-12-16 | 2015-12-16 | Hypochlorous acid formulations and methods for treating skin conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017007852A true MX2017007852A (es) | 2018-01-11 |
Family
ID=56127847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017007852A MX2017007852A (es) | 2014-12-16 | 2015-12-16 | Formulaciones de acido hipocloroso y metodos para tratar afecciones de la piel. |
Country Status (12)
Country | Link |
---|---|
US (1) | US10987379B2 (es) |
EP (1) | EP3233091A4 (es) |
JP (1) | JP2017538755A (es) |
KR (1) | KR20170095312A (es) |
CN (1) | CN107206019B (es) |
AU (1) | AU2015364697A1 (es) |
CA (1) | CA2970804C (es) |
HK (1) | HK1245641A1 (es) |
IL (1) | IL252819A0 (es) |
MX (1) | MX2017007852A (es) |
SG (1) | SG11201704925WA (es) |
WO (1) | WO2016100543A2 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9381214B2 (en) | 2011-03-18 | 2016-07-05 | Puricore, Inc. | Methods for treating skin irritation |
US20150099010A1 (en) | 2013-10-07 | 2015-04-09 | Reoxcyn Discoveries Group, Inc | Redox signaling gel formulation |
US20170202877A1 (en) * | 2016-01-19 | 2017-07-20 | Reoxcyn Discoveries Group, Inc. | Hypochlorite formulations for wound healing |
US11857674B2 (en) | 2016-05-18 | 2024-01-02 | Reoxcyn, Llc | Lubricant formulations |
US9474768B1 (en) | 2016-05-18 | 2016-10-25 | Reoxcyn Discoveries Group, Inc. | Lubricant formulations |
WO2019006217A1 (en) | 2017-06-28 | 2019-01-03 | Collidion, Inc. | COMPOSITIONS, METHODS AND USES FOR CLEANING, DISINFECTION AND / OR STERILIZATION |
US20190099336A1 (en) * | 2017-10-03 | 2019-04-04 | Collidion, Inc. | Compositions, Methods and Uses for Improving a Skin or Hair Region |
SG11202006664UA (en) | 2018-01-14 | 2020-08-28 | Collidion Inc | Compositions, kits, methods and uses for cleaning, disinfecting, sterilizing and/or treating |
BR112021026859A2 (pt) * | 2019-07-03 | 2022-02-22 | Applied Pharma Res | Usos terapêuticos de soluções oxidantes ácidas hipotônicas |
CN115067353A (zh) * | 2021-03-11 | 2022-09-20 | 英属维尔京群岛商白因子国际股份有限公司 | 次氯酸组合物及次氯酸凝胶的制作方法 |
TWI774263B (zh) * | 2021-03-11 | 2022-08-11 | 英屬維京群島商白因子國際股份有限公司 | 次氯酸組合物及其應用 |
CN113082050A (zh) * | 2021-04-26 | 2021-07-09 | 贵州扬生医用器材有限公司 | 一种妇科用温敏凝胶及其制备方法 |
EP4358977A1 (en) * | 2021-06-25 | 2024-05-01 | TTD Global Pty Ltd | Stabilised hypohalous acid solutions |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2355190B (en) * | 1999-08-23 | 2004-07-28 | Sterilox Medical | Improvements in or relating to sterilising preparations |
US6333054B1 (en) | 1999-10-21 | 2001-12-25 | Amuchina S.P.A. | Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
WO2006102681A2 (en) | 2005-03-23 | 2006-09-28 | Oculus Innovative Sciences, Inc. | Method of treating skin ulcers using oxidative reductive potential water solution |
AU2007205861B2 (en) | 2006-01-20 | 2013-05-09 | Oculus Innovative Sciences, Inc. | Methods of treating or preventing sinusitis with oxidative reductive potential water solution |
CN101405013A (zh) * | 2006-01-20 | 2009-04-08 | 奥古露丝创新科学公司 | 使用氧化还原电位水溶液治疗或预防腹膜炎的方法 |
WO2007124591A1 (en) | 2006-05-03 | 2007-11-08 | University Of Manitoba | Microbial markers of inflammatory bowel disease |
WO2008089268A2 (en) | 2007-01-16 | 2008-07-24 | Puricore, Inc. | Methods and compositions for treating conditions associated with infection and/or inflammation |
US9999635B2 (en) | 2007-01-16 | 2018-06-19 | Realm Therapeutics, Inc. | Methods and compositions for treating inflammatory disorders |
WO2009145982A1 (en) * | 2008-04-01 | 2009-12-03 | Antipodean Pharmaceuticals, Inc. | Compositions and methods for skin care |
MX352745B (es) * | 2011-03-18 | 2017-12-04 | Realm Therapeutics Inc | Soluciones estabilizadas de acido hipohaloso. |
US9381214B2 (en) | 2011-03-18 | 2016-07-05 | Puricore, Inc. | Methods for treating skin irritation |
US10617716B2 (en) | 2014-12-16 | 2020-04-14 | Urgo Us, Inc. | Hypochlorous acid formulations and methods for treating skin conditions |
-
2015
- 2015-12-16 WO PCT/US2015/066147 patent/WO2016100543A2/en active Application Filing
- 2015-12-16 EP EP15871006.1A patent/EP3233091A4/en not_active Withdrawn
- 2015-12-16 SG SG11201704925WA patent/SG11201704925WA/en unknown
- 2015-12-16 AU AU2015364697A patent/AU2015364697A1/en not_active Abandoned
- 2015-12-16 MX MX2017007852A patent/MX2017007852A/es unknown
- 2015-12-16 JP JP2017533035A patent/JP2017538755A/ja active Pending
- 2015-12-16 CA CA2970804A patent/CA2970804C/en active Active
- 2015-12-16 KR KR1020177019282A patent/KR20170095312A/ko unknown
- 2015-12-16 CN CN201580076091.XA patent/CN107206019B/zh active Active
-
2017
- 2017-06-11 IL IL252819A patent/IL252819A0/en unknown
-
2018
- 2018-04-18 HK HK18105036.5A patent/HK1245641A1/zh unknown
-
2020
- 2020-03-09 US US16/812,929 patent/US10987379B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
KR20170095312A (ko) | 2017-08-22 |
US10987379B2 (en) | 2021-04-27 |
WO2016100543A3 (en) | 2016-08-18 |
IL252819A0 (en) | 2017-08-31 |
CA2970804C (en) | 2023-01-31 |
CN107206019A (zh) | 2017-09-26 |
HK1245641A1 (zh) | 2018-08-31 |
EP3233091A4 (en) | 2018-07-18 |
CN107206019B (zh) | 2021-09-24 |
WO2016100543A2 (en) | 2016-06-23 |
US20200206263A1 (en) | 2020-07-02 |
JP2017538755A (ja) | 2017-12-28 |
SG11201704925WA (en) | 2017-07-28 |
EP3233091A2 (en) | 2017-10-25 |
AU2015364697A1 (en) | 2017-07-13 |
CA2970804A1 (en) | 2016-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2017007852A (es) | Formulaciones de acido hipocloroso y metodos para tratar afecciones de la piel. | |
MX2019003623A (es) | Composiciones y metodos para el tratamiento de afecciones oftalmicas. | |
MX2021000077A (es) | Composiciones que comprenden cepas bacterianas. | |
MX2018006398A (es) | Composiciones que comprenden cepas bacterianas. | |
MX2018006399A (es) | Composiciones que comprenden cepas bacterianas. | |
MX2017016529A (es) | Composiciones que comprenden cepas bacterianas. | |
MX2017016564A (es) | Composiciones que comprenden cepas bacterianas. | |
MX2017016560A (es) | Composiciones que comprenden cepas bacterianas. | |
MX2017016525A (es) | Composiciones que comprenden cepas bacterianas. | |
MX2021014709A (es) | Composiciones para usarse en el incremento de los niveles de globulos rojos y el tratamiento de enfermedad de celulas falciformes. | |
NZ720949A (en) | Methods and compositions for treating aging-associated conditions | |
EP3099380A4 (en) | Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders | |
PH12018500887A1 (en) | Anti-htra1 antibodies and methods of use thereof | |
MX2023008211A (es) | Composiciones y metodos para disminuir la expresion de tau. | |
EP3273973A4 (en) | Methods and compositions for treating inflammatory and immunological disorders | |
HK1258696A1 (zh) | 治療或預防皮膚障礙的新型組合物和方法 | |
PH12017501864A1 (en) | Compositions and methods for treating autism | |
EP3142664A4 (en) | Compositions and methods for treating and diagnosing ocular disorders | |
ZA201902781B (en) | Compositions and methods for the treatment of xerostomia | |
WO2016141334A9 (en) | Compositions and methods for diagnosing and treating autoimmune diseases | |
MX2017013729A (es) | Deteccion especifica de isoformas de clusterina. | |
BR112018072664A2 (pt) | composições e métodos para tratamento de inflamação e infecção do olho | |
EP3310353A4 (en) | COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF EYE DISEASES | |
WO2017049148A8 (en) | Compositions and methods for the treatment and prevention of radiation dermatitis | |
MX2021008225A (es) | Composiciones y metodos para tratamiento de crecimiento celular anormal. |